Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07290777
What this trial is testing

VEL-101 to Prevent Rejection After Kidney Transplantation

Who this might be right for
Transplantation, Kidney
Veloxis Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Large-scale testing (Phase 3)Study completedNCT02325791
What this trial is testing

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Regeneron Pharmaceuticals 1,177
Large-scale testing (Phase 3)Study completedNCT01455675
What this trial is testing

Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Mukoviszidose Institut gGmbH 164
Post-approval studies (Phase 4)Looking for participantsNCT06799494
What this trial is testing

HPV Vaccine Reduced Dose

Who this might be right for
HPV
Emory University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05663866
What this trial is testing

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Testing effectiveness (Phase 2)Study completedNCT01672853
What this trial is testing

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
Gilead Sciences 235
Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07645833
What this trial is testing

Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension

Who this might be right for
Idiopathic Intracranial Hypertension (IIH)
Rigmor Højland Jensen 96
Large-scale testing (Phase 3)Looking for participantsNCT07015905
What this trial is testing

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Post-approval studies (Phase 4)UnknownNCT01173302
What this trial is testing

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Who this might be right for
Rabies
Peking University People's Hospital 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06812494
What this trial is testing

VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 200
Large-scale testing (Phase 3)Looking for participantsNCT06980480
What this trial is testing

Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency
Takeda 183
Not applicableStudy completedNCT00139139
What this trial is testing

Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A

Who this might be right for
Hepatitis A
Centers for Disease Control and Prevention 1,500
Large-scale testing (Phase 3)Looking for participantsNCT07689630
What this trial is testing

Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06480630
What this trial is testing

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Who this might be right for
Acute Graft Versus Host DiseaseMalignant Hematologic Neoplasm
Anhui Provincial Hospital 39
Testing effectiveness (Phase 2)Study completedNCT03961555
What this trial is testing

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Who this might be right for
Rabies
Synermore Biologics Co., Ltd. 448
Large-scale testing (Phase 3)Study completedNCT04644484
What this trial is testing

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

Who this might be right for
RabiesCommunicable DiseaseVirus Diseases+3 more
Synermore Biologics (Suzhou) Co., Ltd. 1,000
Early research (Phase 1)Active Not RecruitingNCT05890963
What this trial is testing

10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 20
Large-scale testing (Phase 3)Study completedNCT00105183
What this trial is testing

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Who this might be right for
Chronic Obstructive PulmonaryIdiopathic Pulmonary FibrosisCystic Fibrosis+2 more
Neovii Biotech 223
Next Page